Shazia Sofi

1.1k total citations
22 papers, 307 citations indexed

About

Shazia Sofi is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shazia Sofi has authored 22 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shazia Sofi's work include Cancer-related Molecular Pathways (8 papers), Advanced Breast Cancer Therapies (7 papers) and Retinoids in leukemia and cellular processes (3 papers). Shazia Sofi is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Advanced Breast Cancer Therapies (7 papers) and Retinoids in leukemia and cellular processes (3 papers). Shazia Sofi collaborates with scholars based in India, Saudi Arabia and United States. Shazia Sofi's co-authors include Manzoor Ahmad Mir, Hina Qayoom, Umar Mehraj, Abdullah Almilaibary, Shariqa Aisha, Nusrat Jan, Mustfa Alkhanani, Syed Mohammed Basheeruddin Asdaq, Bader Alshehri and Mohd Zahoor ul haq Shah and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Pharmacology and Critical Reviews in Oncology/Hematology.

In The Last Decade

Shazia Sofi

21 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shazia Sofi India 11 167 129 92 69 36 22 307
Shariqa Aisha India 6 175 1.0× 112 0.9× 90 1.0× 57 0.8× 29 0.8× 6 329
Hina Qayoom India 11 214 1.3× 168 1.3× 89 1.0× 76 1.1× 54 1.5× 21 383
Ntlotlang Mokgautsi Taiwan 11 195 1.2× 107 0.8× 90 1.0× 83 1.2× 30 0.8× 24 350
Sheefa Mirza India 13 175 1.0× 120 0.9× 107 1.2× 56 0.8× 13 0.4× 29 372
Daeun You South Korea 12 213 1.3× 159 1.2× 85 0.9× 54 0.8× 16 0.4× 22 438
Helen R. Kim United States 9 213 1.3× 162 1.3× 85 0.9× 50 0.7× 21 0.6× 9 420
Qiongli Su China 13 385 2.3× 140 1.1× 193 2.1× 61 0.9× 24 0.7× 16 527
Lanfang Qin United States 8 301 1.8× 235 1.8× 108 1.2× 87 1.3× 16 0.4× 14 528
Yisun Jeong South Korea 10 179 1.1× 129 1.0× 65 0.7× 40 0.6× 12 0.3× 21 361
Aubhishek Zaman United States 8 223 1.3× 91 0.7× 64 0.7× 40 0.6× 34 0.9× 9 359

Countries citing papers authored by Shazia Sofi

Since Specialization
Citations

This map shows the geographic impact of Shazia Sofi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shazia Sofi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shazia Sofi more than expected).

Fields of papers citing papers by Shazia Sofi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shazia Sofi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shazia Sofi. The network helps show where Shazia Sofi may publish in the future.

Co-authorship network of co-authors of Shazia Sofi

This figure shows the co-authorship network connecting the top 25 collaborators of Shazia Sofi. A scholar is included among the top collaborators of Shazia Sofi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shazia Sofi. Shazia Sofi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sofi, Shazia, et al.. (2025). An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer. Future Oncology. 21(6). 715–735. 6 indexed citations
3.
4.
Qayoom, Hina, Shazia Sofi, Nusrat Jan, et al.. (2024). Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis. Frontiers in Pharmacology. 14. 1333447–1333447. 4 indexed citations
5.
Jan, Nusrat, et al.. (2024). Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology. Heliyon. 10(3). e24670–e24670. 19 indexed citations
6.
Qayoom, Hina, et al.. (2024). Targeting mutant p53: a key player in breast cancer pathogenesis and beyond. Cell Communication and Signaling. 22(1). 484–484. 5 indexed citations
7.
Siebenhaar, Frank, Shazia Sofi, Cem Akin, et al.. (2024). The Mastocytosis Control Test: A Patient-Reported Outcome Measure Assessing Disease Control. The Journal of Allergy and Clinical Immunology In Practice. 13(3). 647–657.e3. 2 indexed citations
8.
Lone, Mohammad Nadeem, et al.. (2023). Synthesis and Biological Evaluation of Novel Uracil Derivatives as Thymidylate Synthase Inhibitors. Applied Biochemistry and Biotechnology. 195(10). 6212–6231. 4 indexed citations
9.
Sofi, Shazia, Umar Mehraj, Nusrat Jan, et al.. (2023). Clinicopathological Significance and Expression Pattern of Bcl2 in Breast Cancer: A Comprehensive in silico and in vitro Study. Saudi Journal of Biological Sciences. 31(2). 103916–103916. 9 indexed citations
10.
Jan, Nusrat, et al.. (2023). Targeting breast cancer stem cells through retinoids: A new hope for treatment. Critical Reviews in Oncology/Hematology. 192. 104156–104156. 16 indexed citations
11.
Qayoom, Hina, Shazia Sofi, & Manzoor Ahmad Mir. (2023). Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis. Immunologic Research. 71(4). 588–599. 27 indexed citations
12.
Shah, Mohd Zahoor ul haq, Vinoy K. Shrivastava, Shazia Sofi, et al.. (2023). Chlorogenic Acid Restores Ovarian Functions in Mice with Letrozole-Induced Polycystic Ovarian Syndrome Via Modulation of Adiponectin Receptor. Biomedicines. 11(3). 900–900. 11 indexed citations
13.
Sofi, Shazia, Nusrat Jan, Hina Qayoom, et al.. (2023). Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation. Saudi Journal of Biological Sciences. 30(9). 103774–103774. 18 indexed citations
14.
Sofi, Shazia, Hina Qayoom, Nusrat Jan, et al.. (2023). A comprehensive analysis of notch signaling genes in breast cancer: Expression pattern and prognostic significance. SHILAP Revista de lepidopterología. 7. 100104–100104. 10 indexed citations
15.
Qayoom, Hina, Umar Mehraj, Shazia Sofi, et al.. (2022). Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study. Medical Oncology. 39(10). 158–158. 10 indexed citations
16.
Sofi, Shazia, et al.. (2022). Identification and analysis of dysregulated fatty acid metabolism genes in breast cancer subtypes. Medical Oncology. 39(12). 256–256. 22 indexed citations
17.
Sofi, Shazia, Umar Mehraj, Hina Qayoom, et al.. (2022). Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors. Medical Oncology. 39(9). 133–133. 59 indexed citations
18.
Sofi, Shazia, Umar Mehraj, Hina Qayoom, et al.. (2022). Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications. Medical Oncology. 39(6). 106–106. 42 indexed citations
19.
Mehraj, Umar, Shazia Sofi, Bader Alshehri, & Manzoor Ahmad Mir. (2022). Expression pattern and prognostic significance of CDKs in breast cancer: An integrated bioinformatic study. Cancer Biomarkers. 34(3). 505–519. 11 indexed citations
20.
Sofi, Shazia, et al.. (2018). RISK FACTORS OF ACID PEPTIC DISEASE AMONG ADULTS ATTENDING THE GENERAL MEDICINE OUTPATIENT DEPARTMENT OF A TERTIARY CARE INSTITUTION IN SOUTH INDIA- A CROSS SECTIONAL STUDY. Journal of Evolution of Medical and Dental Sciences. 7(45). 4834–4838. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026